Jianlei Xie

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 21, 2026
Single-cell transcriptomics and functional validation reveal a TUBB4B-associated malignant epithelial state in nasopharyngeal carcinoma.

|Feb 09, 2026
Advances in organelle-targeted photosensitizer-mediated pyroptosis for photodynamic tumor therapy: overcoming immunological limitations.

Jianlei Xie, Yu Xiao, Baoxin Peng

|Oct 18, 2025
Adipose-derived stem cells inhibit dendritic cell migration by secreting tumor necrosis factor-α-stimulated gene 6 to improve the allogeneic skin transplantation survival rate in mice.

Julong Hu, Wenxu Peng, Yeltai Nurzat

|Aug 26, 2025
Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis.

Jianlei Xie, Baoxin Peng, Yu Xiao

|Aug 02, 2024
Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium.

Zexuan Lian, Ruchong Chen, Mo Xian

Pageof 1

Frequent Collaborators

3 joint publications

Xiaowen Zhang

1 joint publications

Zexuan Lian

1 joint publications

Ruchong Chen

1 joint publications

Mo Xian